Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for extubation time in mechanically ventilated ICU patients
ChiCTR2200065048Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Conditions requiring mechanical ventilation in intensive care unit (MV) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Time from cessation of sedation administration to extubation. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Conditions requiring mechanical ventilation in intensive care unit (MV)
Beyond the preview
Go deeper on ChiCTR2200065048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065048.